Cargando…

Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma

Detalles Bibliográficos
Autores principales:	Tanaka, Yoshihiro, Yoshida, Kazuhiro, Yamada, Atsuko, Tanahashi, Toshiyuki, Okumura, Naoki, Matsuhashi, Nobuhisa, Yamaguchi, Kazuya, Miyazaki, Tatsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969877/ https://www.ncbi.nlm.nih.gov/pubmed/27113368 http://dx.doi.org/10.1007/s00280-016-3016-8

Ejemplares similares

Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
por: Tanaka, Yoshihiro, et al.
Publicado: (2016)

Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma
por: Tanaka, Yoshihiro, et al.
Publicado: (2016)

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study
por: Tanaka, Yoshihiro, et al.
Publicado: (2010)

Novel therapy for locally advanced triple-negative breast cancer
por: YAMADA, ATSUKO, et al.
Publicado: (2015)

Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
por: Akiyama, Yuji, et al.
Publicado: (2018)

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer
por: Tajima, Jesse Yu, et al.
Publicado: (2018)

Laparoscopic technique and safety experience with barbed suture closure for pelvic cavity after abdominoperineal resection
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2013)

The long-term survival of stage IV gastric cancer patients with conversion therapy
por: Yamaguchi, Kazuya, et al.
Publicado: (2017)

A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2018)

A case report on efficacy of Abound™ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2014)

Safety and feasibility of laparoscopic intersphincteric resection for a lower rectal tumor
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2017)

Safety and feasibility of laparoscopic intersphincteric resection for a lower rectal tumor
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2018)

Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report
por: Tokumaru, Yoshihisa, et al.
Publicado: (2019)

Pathological complete response to mFOLFOX6 plus cetuximab therapy for unresectable colon cancer with multiple paraaortic lymph node metastases
por: Suetsugu, Tomonari, et al.
Publicado: (2018)

Feasibility of the Reconstruction with Fascia Lata Patch on the Abdominal Wall Defect After Resection of the Abdominal Desmoid Tumor
por: Goto, Ayana, et al.
Publicado: (2020)

Local recurrence of T1a rectal cancer following radical endoscopic mucosal resection: A case report
por: Matsumoto, Keita, et al.
Publicado: (2018)

Erratum to: Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study
por: Tanaka, Yoshihiro, et al.
Publicado: (2015)

Rectal neuroendocrine tumor developing lateral lymph node metastasis after curative resection: a case report
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification
por: Yoshida, Kazuhiro, et al.
Publicado: (2015)

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer
por: Korkeila, E. A., et al.
Publicado: (2017)

Single-incision laparoscopic ileocecal resection in a 10-year-old child with appendiceal neuroendocrine tumor
por: Goto, Ayana, et al.
Publicado: (2019)

Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer
por: Fuchs, Hannah, et al.
Publicado: (2018)

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
por: Tamaki, Yukihisa, et al.
Publicado: (2018)

Oncologic outcomes of laparoscopic gastrectomy: a single-center safety and feasibility study
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2013)

Erratum to: Transportan 10 improves the anticancer activity of cisplatin
por: Rusiecka, Izabela, et al.
Publicado: (2016)

Impact of preoperative docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy on degree of malignant esophageal stenosis
por: Yamaguchi, Takahisa, et al.
Publicado: (2023)

Erratum to: Synthetic and natural antioxidants attenuate cisplatin-induced vomiting
por: Alam, Javaid, et al.
Publicado: (2017)

Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma()()()()
por: Jin, Ting, et al.
Publicado: (2019)

Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer
por: Fu, Jin Ye, et al.
Publicado: (2022)

Subtotal stomach in esophageal reconstruction surgery achieves an anastomotic leakage rate of less than 1%
por: Yoshida, Kazuhiro, et al.
Publicado: (2020)

Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)
por: Matsusaka, Satoshi, et al.
Publicado: (2015)

Docetaxel-Loaded Solid Lipid Nanoparticles Suppress Breast Cancer Cells Growth with Reduced Myelosuppression Toxicity [Erratum]
Publicado: (2019)

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2019)

The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells
por: Mori, Ryutaro, et al.
Publicado: (2018)

Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study
por: Ishikawa, Takeshi, et al.
Publicado: (2019)

ERRATUM: Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms
por: Kang, Jinho, et al.
Publicado: (2019)

Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
por: Yamaguchi, Kensei, et al.
Publicado: (2012)

Erratum to: Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells
por: Ma, Yuanjun, et al.
Publicado: (2016)

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer [Erratum]
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p7m5jrkjc269ratnsfevk7unh1